TheProfitWatch

ABBV - ABBVIE INC.

Day 1m 10m 60m PreMarket Market AfterHours Gap
227.77 -0.29 (-0.13%) --- --- --- -0.29 (-0.13%) --- 1.52 (0.66%) -1.68 (-0.73%)

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
0.52
Diluted EPS:
0.52
Basic P/E:
437.4615
Diluted P/E:
437.4615
RSI(14) 1m:
0.0
VWAP:
227.49
RVol:
0.0004

Events

Period Kind Movement Occurred At

Related News